Exact Mass: 666.3016276
Exact Mass Matches: 666.3016276
Found 179 metabolites which its exact mass value is equals to given mass value 666.3016276
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Barbinine
A diterpene alkaloid that is a phytotoxin produced by several Delphinium species.
Darapladib
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D004791 - Enzyme Inhibitors > D064801 - Phospholipase A2 Inhibitors Darapladib (SB-480848) is an orally active, selective and reversible Lp-PLA2 inhibitor (IC50=0.25 nM). Darapladib can trigger irreversible actions on glioma cell apoptosis and induce cycle arrest. Darapladib can be used in the study of atherosclerosis and cancer[1][2][3][4].
Protease-Activated Receptor-4
C33H46N8O7 (666.3489285999999)
Syrosingopine
6)-beta-D-glucopyranoside)
Strychnogucine B
A bisindole alkaloid with a strychnine substructure isolated from the roots of Strychnos icaja and has been shown to exhibit antiplasmodial activity.
Caseargrewiin B
A diterpenoid of the clerodane group isolated from the bark of Casearia grewiifolia and has been shown to exhibit antimalarial and antimycobacterial activity.
[(2R,3S,4S,5R,6R)-6-[1,7-bis(4-hydroxyphenyl)-5-oxoheptan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(3,4-dimethoxyphenyl)prop-2-enoate
3,4,7-Trihydroxy-5-methoxy-8-prenylflavan 4-O-(beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranoside)
(+)-pinoresinol 4-O-[beta-glucopyranosyl(1->2)-alpha-rhamnopyranoside]|hibiscuside
2-(3,4-dimethoxyphenyl)-5-(3-hydroxypropyl)-7-methoxybenzofuran-beta-gentiobioside
7-[(acetyloxy)methyl]-4-({[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}oxan-2-yl]oxy}methyl)-6,7-dihydroxy-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
12-O-Benzoyl-14-O-(2E,4E)-decadienoyl-5beta,12beta-dihydroxyresiniferonol-6alpha,7alpha-oxide
1,6-di-O-trityl-galactitol|1,6-di-O-tritylgalactitol|1.6-Bis-O-triphenylmethyl-galaktit|1.6-Bis-triphenylmethoxy-galacto-hexantetrol-(2.3.4.5)|1.6-di-O-trityl-galactitol|1.6-Di-O-trityl-galaktit
2,2,3,3-Tetrahydro-3,3,6,6,7,7-hexamethoxy-4,4-diphenyl-5,5-bi(1H-phenalene)
trichagmalin A
A limonoid with a phragmalin skeleton isolated from the leaves of Trichilia connaroides.
9-hydroxymegastigma-4-en-3-one beta-D-glucopyranosyl-(1->2)-[beta-D-xylopyranosyl-(1->6)]-beta-D-galactopyranoside|oreadoside A
13-de-O-acetylspicachlorantin E|chlorajaponilide E
3beta-[(2-O-sulfo-beta-D-xylopyranosyl)oxy]urs-12,19-diene-28-oic acid|Asprellanoside E
1??,7??,8??-Triacetoxy-2??-furanoyl-4??-hydroxy-11-isobutyryloxy-dihydroagarofuran
(55S,71S)-16,59,76,7-tetramethoxy-56,72-dimethyl-55,6,7,8,71,2,3,4-octahydro-2,6-dioxa-1(1,3),3(1,4)-dibenzena-5(5,4)-[1,3]dioxolo[4,5-g]isoquinolina-7(5,1)-isoquinolina-cyclooctaphane|O6,O7-methanediyl-O5-methyl-20,21-dinor-thalmirabine|Thalfinin|Thalfinine
C39H42N2O8 (666.2941012000001)
6-beta-hydroxy-5-epilimonin 17-beta-D-glucopyranoside
caseargrewiin B|rel-(2R,5S,6R,7R,9S,10S,18R,19S)-18,19-diacetoxy-18,19-epoxy-2-butanoyloxy-6-hydroxy-7-(p-hydroxycinnamoyloxy)cleroda-3,12(Z),14-triene
furan-3-carboxylic acid rel-(3R,4R,5R,5aS,6R,7S,9S,9aS,10R)-4,6,7,10-tetrakis(acetyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-5a-(2-methyl-1-oxopropoxy)methyl-2H-3,9a-methano-1-benzoxepin-5-yl ester
[(2R,3S,4S,5R,6R)-6-[1,7-bis(4-hydroxyphenyl)-5-oxoheptan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(3,4-dimethoxyphenyl)prop-2-enoate
Syrosingopine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent Annotation level-1
Glu Phe Trp Trp
Glu Trp Phe Trp
Glu Trp Trp Phe
Phe Glu Trp Trp
Phe Trp Glu Trp
Phe Trp Trp Glu
Ile Trp Trp Tyr
Ile Trp Tyr Trp
Ile Tyr Trp Trp
Leu Trp Trp Tyr
Leu Trp Tyr Trp
Leu Tyr Trp Trp
Trp Glu Phe Trp
Trp Glu Trp Phe
Trp Phe Glu Trp
Trp Phe Trp Glu
Trp Ile Trp Tyr
Trp Ile Tyr Trp
Trp Leu Trp Tyr
Trp Leu Tyr Trp
Trp Trp Glu Phe
Trp Trp Phe Glu
Trp Trp Ile Tyr
Trp Trp Leu Tyr
Trp Trp Tyr Ile
Trp Trp Tyr Leu
Trp Tyr Ile Trp
Trp Tyr Leu Trp
Trp Tyr Trp Ile
Trp Tyr Trp Leu
Tyr Ile Trp Trp
Tyr Leu Trp Trp
Tyr Trp Ile Trp
Tyr Trp Leu Trp
Tyr Trp Trp Ile
Tyr Trp Trp Leu
1,7-Bis(4-hydroxyphenyl)-5-oxo-3-heptanyl 6-O-[(2E)-3-(3,4-dimethoxyphenyl)-2-propenoyl]-?-D-glucopyranoside
OHHdiA-PG
C31H55O13P (666.3380109999999)
4,4-((1E,1E)-NAPHTHALENE-1,4-DIYLBIS(ETHENE-2,1-DIYL))BIS(N,N-DIPHENYLANILINE)
((4R,5R)-2,2-DIMETHYL-1,3-DIOXOLANE-4,5-DIYL)BIS(DI(NAPHTHALEN-1-YL)METHANOL)
PAR-4 (1-6) amide (mouse) trifluoroacetate salt
C33H46N8O7 (666.3489285999999)
Protease-Activated Receptor-4 is the agonist of proteinase-activated receptor-4 (PAR4).
4,5:4,5-dibenzo-1,1-dibutyl-3,3,3,3-tetramethylindadicarbocyanine perchlorate
(-)-1,6-BIS(2-CHLOROPHENYL)-1,6-DIPHENYL-2,4-HEXADIYNE-1,6-DIOL
(3AR,4R,5R,6AS)-4-((R,E)-3-((TERT-BUTYLDIMETHYLSILYL)OXY)-4-(3-(TRIFLUOROMETHYL)PHENOXY)BUT-1-EN-1-YL)-2-OXOHEXAHYDRO-2H-CYCLOPENTA[B]FURAN-5-YL [1,1-BIPHENYL]-4-CARBOXYLATE
C37H41F3O6Si (666.2624362000001)
[(4S,5S)-5-[hydroxy(dinaphthalen-2-yl)methyl]-2,2-dimethyl-1,3-dioxolan-4-yl]-dinaphthalen-2-ylmethanol
Darapladib
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D004791 - Enzyme Inhibitors > D064801 - Phospholipase A2 Inhibitors Darapladib (SB-480848) is an orally active, selective and reversible Lp-PLA2 inhibitor (IC50=0.25 nM). Darapladib can trigger irreversible actions on glioma cell apoptosis and induce cycle arrest. Darapladib can be used in the study of atherosclerosis and cancer[1][2][3][4].
Methyl reserpate, 4-ethoxycarbonyl-3,5-dimethoxybenzoic acid ester
Ajugaciliatin E
A diterpene lactone isolated from the whole plants of Ajuga ciliata.
chlorajaponilide E, (rel)-
A natural product found in Chloranthus japonicus.
4-(dimethylamino)-N-[[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide
4-(dimethylamino)-N-[[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide
4-(dimethylamino)-N-[[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide
4-(dimethylamino)-N-[[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide
4-(dimethylamino)-N-[[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide
4-(dimethylamino)-N-[[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide
4-(dimethylamino)-N-[[(3R,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide
4-(dimethylamino)-N-[[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide
4-(dimethylamino)-N-[[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide
4-(dimethylamino)-N-[[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide
4-(dimethylamino)-N-[[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide
1-[(3S,9R,10S)-9-[[(4-chlorophenyl)sulfonyl-methylamino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
6-[2-(2,4-dihydroxyphenyl)-3-[(2Z)-3,7-dimethylocta-2,6-dienyl]-7-hydroxy-8-(3-methylbut-2-enyl)-4-oxochromen-6-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[4-[3-[(2E)-3,7-dimethylocta-2,6-dienyl]-6,7-dihydroxy-8-(3-methylbut-2-enyl)-4-oxochromen-2-yl]-3-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[2-(2,4-dihydroxyphenyl)-3-[(2Z)-4-hydroxy-3,7-dimethylocta-2,6-dienyl]-8-(3-methylbut-2-enyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
[1-acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (Z)-tetradec-9-enoate
[1-propanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (Z)-tridec-9-enoate
[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate
C31H55O13P (666.3380109999999)
[1-hexanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
C31H55O13P (666.3380109999999)
[1-butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate
C31H55O13P (666.3380109999999)
[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
C31H55O13P (666.3380109999999)
[1-acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate
C31H55O13P (666.3380109999999)
Aconitan-14-one, 7,8-dihydroxy-20-ethyl-4-(((2-(3-methyl-2,5-dioxo-1-pyrrolidinyl)benzoyl)oxy)methyl)-1,6,16-trimethoxy-, (1-alpha,4(S),6-beta,16-beta)-
17-[(4-ethoxycarbonyloxy-3,5-dimethoxyphenyl)-oxomethoxy]-6,18-dimethoxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylic acid methyl ester
phosphatidylserine 28:6(1-)
A 3-sn-phosphatidyl-L-serine(1-) in which the acyl groups at C-1 and C-2 contain 28 carbons in total and 6 double bonds.
(1R,15S,17R,18R,19S,20S)-17-[(4-ethoxycarbonyloxy-3,5-dimethoxyphenyl)-oxomethoxy]-6,18-dimethoxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylic acid methyl ester
Suc-Ala-Leu-Pro-Phe-pNA
C33H42N6O9 (666.3013122000001)
Suc-Ala-Leu-Pro-Phe-pNA (Suc-ALPF-pNA) is a substrate of FK-506 binding protein (FKBP)[1].
(1s,4as,6s,7r,7as)-7-[(acetyloxy)methyl]-4-({[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}oxan-2-yl]oxy}methyl)-6,7-dihydroxy-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
5,7,8,12-tetrakis(acetyloxy)-2-hydroxy-2,10,10-trimethyl-6-{[(2-methylpropanoyl)oxy]methyl}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-4-yl furan-3-carboxylate
7-[11-(furan-3-yl)-9,13-dimethyl-3-oxo-4,10,21-trioxahexacyclo[16.2.1.0²,⁶.0²,¹⁷.0⁶,¹⁴.0⁹,¹³]henicosa-15,19-dien-20-yl]-9-methyl-6,16-dioxatetracyclo[8.7.0.0¹,¹⁴.0⁴,⁹]heptadeca-10,12-diene-5,15-dione
2-{4-[4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenoxy}-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxane-3,4,5-triol
(1r,11s,18s,20r,21r,22s,24r)-24-[(1r,12r,13r,14e,19s,21s)-14-(2-hydroxyethylidene)-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-10-yl]-12-oxa-8,17-diazaheptacyclo[15.5.2.0¹,¹⁸.0²,⁷.0⁸,²².0¹¹,²¹.0¹⁵,²⁰]tetracosa-2,4,6,14-tetraen-9-one
7-hydroxy-12-{7-hydroxy-8-methoxy-18-oxo-5-propanoyl-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-6(11),7,9,20-tetraen-9-yl}-5,15-diazatetracyclo[10.3.1.0¹,⁵.0⁶,¹¹]hexadeca-6,8,10-triene-4,16-dione
C37H38N4O8 (666.2689508000001)